Crossmark

Effectiveness and health cost analysis between immunoprophylaxis with MV140 autovaccine, MV140 vaccine and continuous treatment with antibiotics to prevent recurrent urinary tract infections

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2022.08.016

Published Print: 2023-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ramírez-Sevilla, C.

Gómez-Lanza, E.

Llopis-Manzanera, J.

Cetina-Herrando, A.

Puyol-Pallàs, J.M.
License Information

Text and Data Mining valid from 2023-01-01
More Information

This article is maintained by: Elsevier

Article Title: Effectiveness and health cost analysis between immunoprophylaxis with MV140 autovaccine, MV140 vaccine and continuous treatment with antibiotics to prevent recurrent urinary tract infections

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2022.08.016

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2022.05.007

Content Type: article

Copyright: © 2022 AEU. Published by Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below